Circa 2018
Bolt Threads–which also makes synthetic spider silk to use in clothes–is debuting a handbag made from mycelium, the root structure of mushrooms.
[Photo: Bolt Threads]
Bay Area based artist-inventor and amateur mycologist Phil Ross has an international patent pending on a method of producing fungus as a sustainable construction material. It may be surprising to hear that a biodegradable, durable, and non-toxic building material is on sale in the vegetable aisle at the supermarket. However, it’s not the tasty caps that Ross is after, but the root-like fibers of mushrooms form an enormous underground tangle called mycelium. Dried mycelium forms a lightweight mold and water resistant fire-proof material that is an effective insulator. It is also very sturdy stuff. Bob Engels of Gourmet Mushrooms notes, “Hardened steel blades on equipment at our farm need regular attention following their encounters with these massed threads of hyphae.”
Ross reported that multiple saw blades and metal files were destroyed while shaping the five hundred mycelium bricks he grew into an archway. The archway was a 6×6 foot sculpture titled Mycotectural Alpha, and was likely the first man-made structure made entirely out of mushrooms. Others have taken notice of the potential of fungus—a new start-up called Evocative Design producing mycelium alternatives to styrofoam and insulation material has received grants from the National Science Foundation, the Environmental Protection Agency, and the Department of Agriculture.
Ross’s “biotechnical” artwork encompasses drawings, paintings, sculptures, prototypes, and extensive materials research. Over the past 15 years he has been experimenting with fungus, growing and shaping mushrooms in sterile laboratory-like environments, even learning to make his own air filters to provide the necessary clean air. He says mycelium bricks can be grown in about a week from a mixture poured into a mold, but the more organic-looking mushroom sculptures that are created by adding or subtracting gas or air from their growing environment can take years to create. the artist explains how the “myotecture” bricks are made:
Bacteria that can help defuse highly toxic dioxin in sediments in the Passaic River—a Superfund hazardous waste site—could eventually aid cleanup efforts at other dioxin-contaminated sites around the world, according to Rutgers scientists.
Their research, published in the journal Environmental Science & Technology, needs further work to realize the full potential of the beneficial bottom-dwelling microbes.
“The bacteria-driven process we observed greatly decreases the toxicity of dioxin,” said senior author Donna E. Fennell, a professor who chairs the Department of Environmental Sciences in the School of Environmental and Biological Sciences at Rutgers University–New Brunswick.
Circa 2015
Solar power plants in Qatar and Jordan, not far from the sea, are powering desalination systems that irrigate plants in and around greenhouses.
An international leader in quantum computing, architect of the U.S. National Quantum Initiative, and member of the National Academy of Sciences, Chris Monroe will join longtime long-distance collaborators at Duke to build practical quantum computers for use in fields from finance to pharmaceuticals.
Another potential explanation is that the heartbeat is illuminated by more diffuse and unstructured outflows of gas and particles generated by the disk’s precession. These outflows are not as concentrated and luminous as the jets, but they could potentially ripple out to Fermi J1913+0515 and light it up in this unique way.
The team is in the midst of collecting follow-up observations with the IRAM 30m millimeter radio telescope in Spain that might constrain the origins of the strange gamma ray heartbeat.
“We discovered the source, and discovered its periodicity, but we do not know what it means or how it is produced, so we need more observations to continue the study,” Li said.
Circa 2014
The waste fibres from hemp crops can be transformed into high-performance energy storage devices, scientists say.
They “cooked” cannabis bark into carbon nanosheets and built supercapacitors “on a par with or better than graphene” — the industry gold standard.
Researchers at Oxford University, in collaboration with DeepMind, University of Basel and Lancaster University, have created a machine learning algorithm that interfaces with a quantum device and ‘tunes’ it faster than human experts, without any human input. They are dubbing it “Minecraft explorer for quantum devices.”
Classical computers are composed of billions of transistors, which together can perform complex calculations. Small imperfections in these transistors arise during manufacturing, but do not usually affect the operation of the computer. However, in a quantum computer similar imperfections can strongly affect its behavior.
In prototype semiconductor quantum computers, the standard way to correct these imperfections is by adjusting input voltages to cancel them out. This process is known as tuning. However, identifying the right combination of voltage adjustments needs a lot of time even for a single quantum device. This makes it virtually impossible for the billions of devices required to build a useful general-purpose quantum computer.
This approach to increasing capacity will be particularly important as robots shrink to the microscale and below—scales at which current stand-alone batteries are too big and inefficient.
“Robot designs are restricted by the need for batteries that often occupy 20% or more of the available space inside a robot, or account for a similar proportion of the robot’s weight,” said Nicholas Kotov, the Joseph B. and Florence V. Cejka Professor of Engineering, who led the research.
Continue reading “Biomorphic batteries could provide 72x more energy for robots” »
In a bitter paradox, antibiotics fuelled the growth of the twentieth century’s most profitable pharmaceutical companies, and are one of society’s most desperately needed classes of drug. Yet the market for them is broken. For almost two decades, the large corporations that once dominated antibiotic discovery have been fleeing the business, saying that the prices they can charge for these life-saving medicines are too low to support the cost of developing them. Most of the companies now working on antibiotics are small biotechnology firms, many of them running on credit, and many are failing.
Paratek Pharmaceuticals successfully brought a new antibiotic to the market. So why is the company’s long-term survival in question?
